Your browser doesn't support javascript.
loading
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial.
Pérez-García, José Manuel; Vaz Batista, Marta; Cortez, Patricia; Ruiz-Borrego, Manuel; Cejalvo, Juan Miguel; de la Haba-Rodriguez, Juan; Garrigós, Laia; Racca, Fabricio; Servitja, Sonia; Blanch, Salvador; Gion, María; Nave, Monica; Fernández-Abad, María; Martinez-Bueno, Alejandro; Llombart-Cussac, Antonio; Sampayo-Cordero, Miguel; Malfettone, Andrea; Cortés, Javier; Braga, Sofía.
Afiliação
  • Pérez-García JM; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.
  • Vaz Batista M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.
  • Cortez P; Medica Scientia Innovation Research (MEDSIR), Ridgewood, New Jersey, USA.
  • Ruiz-Borrego M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.
  • Cejalvo JM; Medica Scientia Innovation Research (MEDSIR), Ridgewood, New Jersey, USA.
  • de la Haba-Rodriguez J; Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal.
  • Garrigós L; IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Madrid, Spain.
  • Racca F; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Servitja S; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Blanch S; Instituto Maimonides de Investigacion Biomedica, Hospital Reina Sofia, Universidad de Córdoba, Córdoba, Spain.
  • Gion M; International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain.
  • Nave M; Hospital Universitari Dexeus, Barcelona, Spain.
  • Fernández-Abad M; IOB Institute of Oncology, Quiron Group, Madrid and Barcelona, Spain.
  • Martinez-Bueno A; Hospital del Mar, Barcelona, Spain.
  • Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.
  • Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Ridgewood, New Jersey, USA.
  • Malfettone A; Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal.
  • Cortés J; Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Braga S; University Hospital Ramon y Cajal, Madrid, Spain.
Neuro Oncol ; 25(1): 157-166, 2023 01 05.
Article em En | MEDLINE | ID: mdl-35639825
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha